Valeo Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,417
| Closed | -$206K | – | 711 |
|
|
2024
Q3 | $206K | Buy |
+1,417
| New | +$206K | 0.01% | 643 |
|
|
2023
Q2 | – | Sell |
-2,135
| Closed | -$276K | – | 618 |
|
|
2023
Q1 | $276K | Buy |
2,135
+486
| +29% | +$62.8K | 0.01% | 465 |
|
|
2022
Q4 | $216K | Buy |
+1,649
| New | +$216K | 0.01% | 466 |
|
|
2022
Q2 | – | Sell |
-3,185
| Closed | -$415K | – | 532 |
|
|
2022
Q1 | $415K | Buy |
3,185
+881
| +38% | +$115K | 0.02% | 350 |
|
|
2021
Q4 | $352K | Hold |
2,304
| – | – | 0.02% | 368 |
|
|
2021
Q3 | $373K | Sell |
2,304
-400
| -15% | -$64.8K | 0.02% | 342 |
|
|
2021
Q2 | $442K | Buy |
2,704
+717
| +36% | +$117K | 0.03% | 268 |
|
|
2021
Q1 | $299K | Sell |
1,987
-109
| -5% | -$16.4K | 0.01% | 349 |
|
|
2020
Q4 | $318K | Sell |
2,096
-76
| -3% | -$11.5K | 0.02% | 315 |
|
|
2020
Q3 | $294K | Sell |
2,172
-3
| -0.1% | -$406 | 0.03% | 252 |
|
|
2020
Q2 | $297K | Buy |
2,175
+11
| +0.5% | +$1.5K | 0.03% | 250 |
|
|
2020
Q1 | $246K | Sell |
2,164
-1,781
| -45% | -$202K | 0.03% | 256 |
|
|
2019
Q4 | $475K | Buy |
3,945
+2,955
| +298% | +$356K | 0.05% | 198 |
|
|
2019
Q3 | $99K | Sell |
990
-1,010
| -51% | -$101K | 0.01% | 439 |
|
|
2019
Q2 | $218K | Sell |
2,000
-547
| -21% | -$59.6K | 0.03% | 270 |
|
|
2019
Q1 | $285K | Buy |
2,547
+1,800
| +241% | +$201K | 0.03% | 225 |
|
|
2018
Q4 | $72K | Sell |
747
-84
| -10% | -$8.1K | 0.01% | 431 |
|
|
2018
Q3 | $86K | Buy |
831
+84
| +11% | +$8.69K | 0.01% | 430 |
|
|
2018
Q2 | $87K | Hold |
747
| – | – | 0.01% | 422 |
|
|
2018
Q1 | $80K | Sell |
747
-15
| -2% | -$1.61K | 0.01% | 402 |
|
|
2017
Q4 | $81K | Buy |
762
+120
| +19% | +$12.8K | 0.01% | 378 |
|
|
2017
Q3 | $71K | Buy |
+642
| New | +$71K | 0.02% | 344 |
|